Changeflow GovPing Healthcare Atrial Fibrillation Trigger Detection Using Ele...
Routine Notice Added Final

Atrial Fibrillation Trigger Detection Using Electrode Signal Correlation

Favicon for changeflow.com ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B)
Published April 2nd, 2026
Detected April 2nd, 2026
Email

Summary

USPTO published Biosense Webster (Israel) Ltd.'s patent application (US20260090756A1) for a method of detecting atrial fibrillation triggers using composite correlation scores based on signals from multiple electrodes. The invention relates to electro-anatomical mapping systems that identify suspected AF trigger locations in the heart by analyzing electrode signal correlations. Application No. 18903377 was filed October 1, 2024.

What changed

The USPTO published a patent application disclosing a method for identifying atrial fibrillation trigger sites using electrode signal correlation analysis. The system determines composite correlation scores for selected spatial locations in the heart based on correlations between signals from a selected electrode positioned at that location and signals from other electrodes. The electro-anatomical map displays these scores to indicate suspected AF trigger locations. Assignee: Biosense Webster (Israel) Ltd.; Inventors: Haim Rodriguez, Matityahu Amit.

This publication is a routine patent application notice with no compliance requirements for third parties. Entities developing cardiac mapping or ablation technologies should review the disclosed correlation methodology for potential overlap with existing development programs. Patent publications do not create regulatory obligations but may inform freedom-to-operate analyses.

Source document (simplified)

← USPTO Patent Applications

IDENTIFICATION OF SITES CORRESPONDING TO SUSPECTED ATRIAL FIBRILLATION TRIGGERS BASED ON CORRELATION OF SIGNALS FROM MULTIPLE ELECTRODES

Application US20260090756A1 Kind: A1 Apr 02, 2026

Assignee

Biosense Webster (Israel) Ltd.

Inventors

Haim Rodriguez, Matityahu Amit

Abstract

A composite correlation score associated with a selected spatial location in the heart is determined based on a plurality of individual correlation values, each of which is based on a correlation between a signal associated with a selected electrode positioned at the selected spatial location and a signal associated with another one of the plurality of electrodes when the selected electrode is positioned at the selected spatial location. Composite correlation scores associated other selected spatial locations in the heart are determined the same way. An electro-anatomical map of the heart is displayed which depicts information representative of the composite correlation score determined for the selected spatial locations, including information indicating that a spatial location is a suspected trigger of AF.

CPC Classifications

A61B 5/361 A61B 5/287 A61B 5/308 A61B 5/339

Filing Date

2024-10-01

Application No.

18903377

View original document →

Named provisions

Abstract CPC Classifications

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260090756A1

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Medical Device Manufacturing Cardiac Ablation Technology
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Topics
Healthcare Pharmaceuticals

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.